Your browser doesn't support javascript.
loading
Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension.
Santos, Raul D; Duell, P Barton; East, Cara; Guyton, John R; Moriarty, Patrick M; Chin, Wai; Mittleman, Robert S.
  • Santos RD; Heart Institute (InCor) University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil raul.santos@incor.usp.br rdsf@uol.com.br.
  • Duell PB; Oregon Health and Science University, Portland, OR, USA.
  • East C; Soltero Cardiovascular Research Center Baylor University Medical Center, Dallas, TX, USA.
  • Guyton JR; Duke University Medical Center, Durham, NC, USA.
  • Moriarty PM; Kansas University Atherosclerosis & LDL-Apheresis Center, Kansas City, KS, USA.
  • Chin W; Genzyme Corporation, Cambridge, MA, USA.
  • Mittleman RS; Genzyme Corporation, Cambridge, MA, USA.
Eur Heart J ; 36(9): 566-75, 2015 Mar 01.
Article en En | MEDLINE | ID: mdl-24366918
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligonucleótidos / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Etiology_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligonucleótidos / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Etiology_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article